Brief: Allarity Therapeutics Inc Says Entered Into At-The-Market Issuance Sales Agreement With Ascendiant Capital Markets
20/03/2024 10:21
March 20 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS INC - ON MARCH 19, ENTERED INTO
AT-THE-MARKET ISSUANCE SALES AGREEMENT WITH ASCENDIANT CAPITAL
MARKETS
* ALLARITY THERAPEUTICS INC - PURSUANT TO AGREEMENT,CO MAY
OFFER
AND SELL, FROM TIME TO TIME, OFFERING PRICE OF UP TO $947,000
Source text for Eikon: ID:n0001213900-24-024156
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic